0000899243-19-002640.txt : 20190205
0000899243-19-002640.hdr.sgml : 20190205
20190205165502
ACCESSION NUMBER: 0000899243-19-002640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171130
FILED AS OF DATE: 20190205
DATE AS OF CHANGE: 20190205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibbs Michael Terrence
CENTRAL INDEX KEY: 0001665000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 19568646
MAIL ADDRESS:
STREET 1: 12 STONEY BROOK RD.
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-30
0
0001492674
T2 Biosystems, Inc.
TTOO
0001665000
Gibbs Michael Terrence
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
General Counsel
Common Stock
2017-11-30
4
M
0
6500
A
50687
D
Common Stock
2018-11-30
4
M
0
6500
A
57187
D
Common Stock
2019-01-31
4
S
0
939
3.35
D
56248
D
Common Stock
2019-02-01
4
S
0
1820
3.47
D
54428
D
Restricted Stock Units
2017-11-30
4
M
0
6500
0.00
D
Common Stock
6500
0
D
Restricted Stock Units
2018-11-30
4
M
0
6500
0.00
D
Common Stock
6500
0
D
Each restricted stock units ("RSU's") represents a contingent right to receive one share of the Issuer's common stock.
Includes 1,220 shares acquired under the Issuer's employee stock purchase plan on November 15, 2018.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.32 to $3.39. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.34 to $3.55. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On November 30, 2016 the reporting person was granted 13,000 RSU's that vested in two equal annual installments beginning on November 30, 2017.
/s/ John Sprague, Attorney-in-fact
2019-02-05